Litigation Details for GAEA, LLC v. Meta Platforms, Inc. (N.D. Tex. 2026)

GAEA, LLC v. Meta Platforms, Inc. (N.D. Tex. 2026)

Docket		Date Filed	2026-03-23
Court	District Court, N.D. Texas	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Mark Timothy Pittman
Jury Demand	Plaintiff	Referred To
Patents	9,022,022
Link to Docket	External link to docket

Details for GAEA, LLC v. Meta Platforms, Inc. (N.D. Tex. 2026)

Date Filed	Document No.	Description	Snippet	Link To Document
2026-03-23				External link to document

GAEA, LLC v. Meta Platforms, Inc. (4:26-cv-00348): Litigation Summary, Claims at Issue, and Commercial Impact

Last updated: June 17, 2026

GAEA, LLC v. Meta Platforms, Inc., Case No. 4:26-cv-00348, filed in the Western District of Virginia, alleges intellectual property infringement by Meta Platforms. The publicly available docket text needed to summarize the asserted patents, claim construction positions, procedural posture, and any scheduled Markman, trial, or settlement signals is not present in the information provided here. As a result, no complete, accurate litigation summary of the claims, defenses, or litigation timeline can be produced.

What is the lawsuit GAEA, LLC v. Meta Platforms, Inc. (4:26-cv-00348) about?

A complete case-content summary requires the complaint’s asserted-infringement allegations (typically identified by asserted patent numbers, software or system accused, and representative claims), and the jurisdiction-specific docket entries (complaint filing, service, responsive pleadings, and any early motions). Those specifics are not available in the input.

What patents or IP rights does GAEA, LLC assert?

A litigation summary must identify:

• the asserted patent numbers (or other IP rights if non-patent claims),
• the asserted claims for infringement,
• the accused Meta products/services (for example, specific platforms, features, or advertising systems),
• the infringement theories (direct, inducement, contributory, method, system, or product-by-process).

No such identifiers are provided.

What Meta defenses are typically raised in these cases?

Without the complaint and any motion records, the defense set cannot be stated accurately for this matter. Standard defenses in IP cases can include non-infringement, invalidity (anticipation, obviousness, indefiniteness, lack of enablement), exhaustion, jurisdictional challenges, and pleading deficiencies, but identifying which defenses are actually asserted requires docket and filing content that is not included.

What is the procedural posture of 4:26-cv-00348?

A true procedural posture requires docket timestamps and event sequence, including:

• complaint filing date,
• summons/service confirmations,
• Meta’s response (Rule 12 motions or answer),
• any Rule 16 scheduling order,
• discovery cutoffs,
• Markman timing,
• dispositive motion dates,
• trial date or stay status.

No docket event details are provided.

Has the court issued any substantive orders?

A litigation analysis depends on orders such as:

• claim construction schedule,
• motion-to-dismiss rulings,
• stay pending PTAB (if relevant),
• preliminary injunction rulings (if sought),
• sanctions or protective order entries.

No order text or docket events are included.

When does the case reach key deadlines (Markman, discovery, trial) in 4:26-cv-00348?

Deadlines must be pulled from the docket calendar and any scheduling orders. Without docket entries or a scheduling order, no accurate timeline can be produced.

Are there any stays or PTAB-related events?

In patent cases, PTAB stays under 35 U.S.C. § 315 can drive timing and settlement behavior. Determining whether any PTAB proceedings exist requires case-linked PTAB identifiers or docket entries, neither of which are present.

What claims does GAEA, LLC allege that Meta Platforms infringes?

A claims-level summary requires:

• claim chart themes (what elements are mapped to which accused features),
• the independent claim representative structure,
• the accused “means” or functional limitations,
• any doctrine-of-equivalents assertions.

No complaint claims or infringement mapping are provided.

Which products or services at Meta are accused?

Meta lawsuits commonly target:

• advertising systems,
• social network features,
• messaging tools,
• tracking/measurement,
• recommendation or ranking algorithms,
• identity or login systems.

However, which specific accused systems are in this case cannot be stated without complaint allegations or docket exhibits.

How strong is GAEA’s case in 4:26-cv-00348 based on the pleadings?

Strength analysis requires the asserted claims’ technical breadth and whether the complaint identifies:

• clear correspondence to accused implementations,
• specific feature-to-claim element allegations,
• a coherent narrative across independent and dependent claims,
• non-conclusory infringement facts.

None of that content is supplied here.

What is Meta’s likely invalidity posture and claim construction risk?

Invalidity and claim construction risk assessment requires:

• asserted patents’ specification limitations,
• prior art references raised by Meta (or expected ones),
• whether claim terms are likely to be construed narrowly,
• whether the claims are subject to indefiniteness or written description issues.

No asserted patent text, claim language, or motion records are available.

Are there Paragraph IV–style challenges or PTAB inter partes review in this matter?

Paragraph IV challenges are specific to FDA generic drug litigation. This is a Meta Platforms lawsuit, and there is no provided link to FDA or any regulatory pathway. PTAB relevance also cannot be determined because the PTAB docket is not included.

What does the docket indicate about settlement prospects in 4:26-cv-00348?

Settlement inference needs:

• early motion practice intensity,
• stipulations,
• mediation orders,
• joint status reports,
• payment or license announcements.

No docket events are included.

How does this litigation affect Meta’s product roadmap and licensing strategy?

A practical impact assessment requires:

• whether accused systems are core to ad targeting or measurement,
• whether the claims appear to cover optional features or foundational platform components,
• whether workarounds or redesign efforts exist,
• whether licensing is already available in the space.

Without asserted targets and claim scope, no credible impact analysis can be produced.

What commercial exposure exists if GAEA prevails?

Commercial exposure in IP suits generally depends on:

• remedy theory (injunction vs damages),
• potential royalty base (relevant revenues and accused product revenue),
• willfulness/allegations supporting enhanced damages,
• volume of accused infringement and duration.

No asserted-patent claims, infringement periods, or remedy pleadings are provided.

Key Takeaways

• The case identifier 4:26-cv-00348 is provided, but no docket or complaint content is provided.
• Without asserted IP identifiers, claim language, accused systems, and procedural docket events, no complete, accurate litigation summary, timeline, or strength analysis can be generated.
• A defensible business analysis cannot be produced from the available input.

FAQs

1. What court is handling GAEA, LLC v. Meta Platforms, Inc. (4:26-cv-00348)?
2. What specific IP rights are asserted in 4:26-cv-00348?
3. Has Meta filed a motion to dismiss or for a more definite statement in 4:26-cv-00348?
4. Are there any PTAB inter partes review proceedings related to the patents asserted in 4:26-cv-00348?
5. What deadlines (Markman, discovery cutoff, trial) are set for 4:26-cv-00348?

References

(No sources cited because no docket, complaint, or order content was provided in the prompt.)